Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Advanced Research Technologies Inc.

Facebook Twitter LinkedIn Email Comments
Advanced Research Technologies Inc. of Saint-Laurent, Quebec, Canada, has announced clinical trials for the SoftScan optical breast imaging system. The device uses time-domain optical imaging to characterize tumors as benign or malignant. Differences in optical signatures between tissues indicate vascularization, cellularity, oxygen consumption, edema, fibrosis and remodeling.

The study will continue through 2006 at several North American centers and examine 600 to 950 volunteer patients age 25 to over 60. The company intends to present results in its submission to Health Canada and the FDA to support its premarket approval application.

May 2006

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.